Walder Wyss advised the investors while VISCHER acted as legal advisor to Nouscom in the transaction.Nouscom, a clinical stage immuno-oncology company developing off-the-shelf and personalized viral…
Nouscom’s €67.5 Million Oversuscribed Series C Financing Round
